Can a risk model survive messy screening data?
Multi-modality imaging evaluation, nationwide HER2-Low cohort analysis, breast density AI, and Wāhine Māori health equity.
Massey University & University of Auckland — one integrated cohort
Breast cancer risk modelling, endocrine therapy adherence, embryo selection AI, and reproducible research methods — from statistical problem to clinical decision.
Multi-modality imaging evaluation, nationwide HER2-Low cohort analysis, breast density AI, and Wāhine Māori health equity.
Morphokinetic stage detection, embryo annotation and segmentation, and cohort-relative ranking behind WyldBloom's clinic tools.
Cohort-relative embryo ranking and lab automation tools now running in NZ fertility clinics.
Open tools and workflows that make translational research auditable from raw data to published conclusion.

Research into practice · WyldBloom
AI, imaging, and clinical decision support turn embryo development into structured, traceable observations — supporting judgement rather than replacing it.
Visit WyldBloom ↗“Artificial Intelligence Enabled IVF”
“AI-driven breast cancer screening equity for Aotearoa”
“Epidemiology of early-onset cancers with a focus on breast cancer”
“Histological and molecular subtypes of breast cancer in NZ women”
I take students who want to build things that leave the building.
How to join →